Russia completes clinical trials of second potential COVID-19 vaccine - RIA


  • World
  • Wednesday, 30 Sep 2020

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration//File Photo

MOSCOW (Reuters) - Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.

The institute completed early-stage human trials, known as Phase II, earlier this month.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Chinese books draw attention at int'l book fair in Algerian capital
U.S. stocks close lower as post-election rally cools
EU Commission urges Apple to end geo-blocking
U.S. stocks close lower
1st Middle East consumer electronics expo kicks off in UAE
Feature: Music provides cultural bridge between China, Italy
Jailed Belarusian dissident Kalesnikava permitted visit from father
How will the next leader of the Church of England be picked?
Crude futures settle higher
U.S. dollar ticks up

Others Also Read